These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 20959406)
21. The value of symptom directed evaluation in the surveillance for recurrence of carcinoma of the breast. Wagman LD; Sanders RD; Terz JJ; Beatty JD; Kokal WA; Riihimaki DU Surg Gynecol Obstet; 1991 Mar; 172(3):191-6. PubMed ID: 1994495 [TBL] [Abstract][Full Text] [Related]
22. Palliative approaches to the patient with breast cancer. Bartus CM; Schreiber JS; Kurtzman SH Surg Oncol Clin N Am; 2004 Jul; 13(3):517-30, ix. PubMed ID: 15236733 [TBL] [Abstract][Full Text] [Related]
23. Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy. Jobsen JJ; Van Der Palen J; Ong F; Meerwaldt JH Acta Oncol; 2007; 46(2):172-80. PubMed ID: 17453365 [TBL] [Abstract][Full Text] [Related]
24. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516 [TBL] [Abstract][Full Text] [Related]
25. Re-evaluation of prognostic mitotic figure counting in breast cancer: results of a prospective clinical follow-up study. Biesterfeld S; Reitmaier M Anticancer Res; 2001; 21(1B):589-94. PubMed ID: 11299810 [TBL] [Abstract][Full Text] [Related]
26. High-dose chemotherapy and stem cell transplantation does not improve relapse-free or overall survival in women with high-risk breast cancer. Carlson RW; Wheatley K Cancer Treat Rev; 2004 Feb; 30(1):131-7. PubMed ID: 14766131 [No Abstract] [Full Text] [Related]
27. Re: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. Verschraegen C; Vinh-Hung V J Natl Cancer Inst; 2004 Jul; 96(14):1111-2. PubMed ID: 15265977 [No Abstract] [Full Text] [Related]
28. The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study. Montero AJ; Rouzier R; Lluch A; Theriault RL; Buzdar AU; Delaloge S; Bermejo B; Le M; Kau SW; Dunant A; Arriagada R; Spielmann M; Garcia-Conde J; Sahin AA; Singletary SE; Hortobagyi GN; Valero V Cancer; 2005 Jul; 104(2):229-35. PubMed ID: 15937910 [TBL] [Abstract][Full Text] [Related]
29. Treatment of carcinoma of the breast in the older geriatric patient. Swanson RS; Sawicka J; Wood WC Surg Gynecol Obstet; 1991 Dec; 173(6):465-9. PubMed ID: 1948604 [TBL] [Abstract][Full Text] [Related]
30. Achieving local control for inflammatory carcinoma of the breast. Sener SF; Imperato JP; Khandekar JD; Ragin A; Beck J; Merkel DE Surg Gynecol Obstet; 1992 Aug; 175(2):141-4. PubMed ID: 1636139 [TBL] [Abstract][Full Text] [Related]
31. [The supraclavicular recurrence of breast carcinoma]. Hirn-Stadler B Strahlenther Onkol; 1990 Dec; 166(12):774-7. PubMed ID: 2125151 [TBL] [Abstract][Full Text] [Related]
32. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Spiegel D; Bloom JR; Kraemer HC; Gottheil E Lancet; 1989 Oct; 2(8668):888-91. PubMed ID: 2571815 [TBL] [Abstract][Full Text] [Related]
33. Primary inflammatory carcinoma of the female breast: staging and treatment possibilities. McBride CM; Hortobagyi GN Surgery; 1985 Oct; 98(4):792-8. PubMed ID: 4049251 [TBL] [Abstract][Full Text] [Related]
34. [The therapy of advanced breast carcinoma in men]. Renziehausen L; Quietzsch D Dtsch Med Wochenschr; 1992 Jan; 117(5):172-6. PubMed ID: 1735376 [TBL] [Abstract][Full Text] [Related]
35. Mega-dose vitamin and mineral therapy in breast cancer: a clinician's perspective. Block KI Integr Cancer Ther; 2003 Jun; 2(2):163-5. PubMed ID: 15035906 [No Abstract] [Full Text] [Related]
36. Refined measurement of outcome for adjuvant breast carcinoma therapy. Gamel JW; Bonadonna G; Valagussa P; Edwards MJ Cancer; 2003 Mar; 97(5):1139-46. PubMed ID: 12599218 [TBL] [Abstract][Full Text] [Related]
37. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications. Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898 [TBL] [Abstract][Full Text] [Related]
38. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Kissane DW; Grabsch B; Clarke DM; Smith GC; Love AW; Bloch S; Snyder RD; Li Y Psychooncology; 2007 Apr; 16(4):277-86. PubMed ID: 17385190 [TBL] [Abstract][Full Text] [Related]
39. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience. Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583 [TBL] [Abstract][Full Text] [Related]
40. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories. Yau TK; Soong IS; Chan K; Chan M; Cheung P; Lau HW; Chang AT; Lee AW Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):667-72. PubMed ID: 17379441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]